13F filer · CIK 2103725
AIHC Capital Management Ltd
CENTRAL, K3 · filing since Q4 2025 · last filing Aug 13, 2026
Reported value
$104.2M
$-15.4M vs prior
Positions
4
New / sold out
0 / 1
Added / reduced
2 / 1
Turnover
14.3%
buys $16.0M · sells $100.5M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ORIC PHARMACEUTICALS INC | +1,368,909 | +55.7% | +$14.8M |
| Added | NOVABRIDGE BIOSCIENCES | +615,100 | +27.2% | +$1.2M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | REVOLUTION MEDICINES INC | -525,841 | -63.4% | $-98.5M |
| Sold out | COGENT BIOSCIENCES INC | -51,402 | -100.0% | $-2.0M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INCCOM | 303,133 | $56.8M | 54.46% |
| 2 | ORIC PHARMACEUTICALS INCCOM | 3,828,460 | $41.5M | 39.77% |
| 3 | NOVABRIDGE BIOSCIENCESSPONSORED ADS | 2,878,033 | $5.6M | 5.38% |
| 4 | KORRO BIO INCCOM | 30,265 | $398.9K | 0.38% |